If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Forteo ® (teriparatide injection)
20-mcg daily dose in a 2.4-mL prefilled delivery device
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What are the alternate injection sites for FORTEO® (teriparatide injection)?
Teriparatide should be administered by subcutaneous injection in the thigh or abdomen.
Administration of Teriparatide
Teriparatide should be administered once daily by subcutaneous injection in the thigh or abdomen.1
In clinical trials, teriparatide was injected subcutaneously into the patient’s thigh or abdominal wall.1
The upper arm is an acceptable area for subcutaneous injection; however, there are no data available on the injection of teriparatide at this site.2
Intravenous or Intramuscular Injection
Teriparatide is not approved for intravenous or intramuscular use.1
Instructions for Teriparatide Injection
Please review the FORTEO® User Manual for instructions on how to properly inject teriparatide.
Enclosed Prescribing Information
1Forteo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
2Subcutaneous (SQ) injections. MedlinePlus website. Updated October 23, 2021. Accessed October 10, 2022. https://medlineplus.gov/ency/patientinstructions/000430.htm
Date of Last Review: September 30, 2022